US stocks MEIP rose more than 33% today, and its market value rose to US$41.24 million
MEI Pharma (NASDAQ code: MEIP) rose more than 33% today, with a market value of $412.31 million.
Earlier news, Titan Partners Group and the cryptocurrency investment company GSR are jointly leading the strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ code: MEIP), promoting the establishment of a dedicated Litecoin treasury strategy. Currently, there are over $100 million in funding commitments for this project. Litecoin founder Charlie Lee has agreed to join the MEI Pharma board of directors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CandyBomb x MCAT: Trade to share 60,000 USDT
CandyBomb x MCAT: Trade to share 60,000 USDT
8 years of companionship, the story continues.
Trend-following bot upgrade: Custom parameter settings now supported
Crypto prices
More
